Oric Pharmaceuticals Stock Price Prediction

ORIC Stock  USD 9.97  0.17  1.73%   
At the present time, the RSI of Oric Pharmaceuticals' share price is approaching 40. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Oric Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

40

 
Oversold
 
Overbought
The successful prediction of Oric Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Oric Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Oric Pharmaceuticals' stock price prediction:
EPS Estimate Next Quarter
(0.49)
EPS Estimate Current Year
(1.82)
EPS Estimate Next Year
(2.11)
Wall Street Target Price
18.7273
EPS Estimate Current Quarter
(0.48)
Using Oric Pharmaceuticals hype-based prediction, you can estimate the value of Oric Pharmaceuticals from the perspective of Oric Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Oric Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Oric because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Oric Pharmaceuticals after-hype prediction price

    
  USD 9.97  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Oric Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide.
Intrinsic
Valuation
LowRealHigh
8.2312.0615.89
Details
12 Analysts
Consensus
LowTargetHigh
14.4315.8617.60
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.58-0.53-0.47
Details

Oric Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Oric Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Oric Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Oric Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Oric Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Oric Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Oric Pharmaceuticals' historical news coverage. Oric Pharmaceuticals' after-hype downside and upside margins for the prediction period are 6.14 and 13.80, respectively. We have considered Oric Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
9.97
9.97
After-hype Price
13.80
Upside
Oric Pharmaceuticals is somewhat reliable at this time. Analysis and calculation of next after-hype price of Oric Pharmaceuticals is based on 3 months time horizon.

Oric Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Oric Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Oric Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Oric Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.01 
3.83
 0.00  
 0.00  
8 Events / Month
11 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
9.97
9.97
0.00 
12,767  
Notes

Oric Pharmaceuticals Hype Timeline

Oric Pharmaceuticals is now traded for 9.97. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Oric is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.01%. %. The volatility of related hype on Oric Pharmaceuticals is about 3898.8%, with the expected price after the next announcement by competition of 9.97. About 91.0% of the company shares are owned by institutional investors. The book value of Oric Pharmaceuticals was now reported as 3.88. The company recorded a loss per share of 1.82. Oric Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days.
Check out Oric Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide.

Oric Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Oric Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Oric Pharmaceuticals' future price movements. Getting to know how Oric Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Oric Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
SEERSeer Inc 0.02 5 per month 1.79  0.17  6.32 (3.03) 15.38 
ANEBAnebulo Pharmaceuticals 0.03 5 per month 0.00 (0.03) 8.61 (11.48) 76.00 
CGEMCullinan Oncology LLC 1.25 10 per month 0.00 (0.17) 5.88 (7.24) 17.85 
CCCCC4 Therapeutics(0.35)10 per month 0.00 (0.11) 8.59 (7.98) 23.66 
MOLNMolecular Partners AG(0.10)5 per month 0.00 (0.02) 9.38 (8.53) 52.92 
MLYSMineralys Therapeutics, Common 0.14 8 per month 3.38  0.01  6.27 (5.79) 20.98 
ANTXAN2 Therapeutics 0.00 10 per month 1.86  0.05  3.73 (3.42) 28.03 
PHVSPharvaris BV(0.23)5 per month 3.19  0.06  7.76 (6.64) 21.41 
PEPGPepGen 0.39 8 per month 0.00 (0.21) 5.12 (9.02) 26.81 
HOWLWerewolf Therapeutics(0.14)5 per month 4.47 (0.01) 8.54 (8.55) 49.02 
EWTXEdgewise Therapeutics 1.60 9 per month 2.82  0.11  6.65 (4.70) 61.02 
DBTXDecibel Therapeutics 0.01 1 per month 4.12  0.05  7.85 (7.45) 26.09 
CELCCelcuity LLC(0.36)7 per month 0.00 (0.16) 4.55 (5.83) 16.97 
THRXTheseus Pharmaceuticals 0.14 2 per month 0.00 (0.06) 11.75 (8.57) 90.33 
PMVPPmv Pharmaceuticals(0.1)3 per month 1.99 (0.03) 3.75 (3.64) 13.98 
ELVNEnliven Therapeutics(0.55)9 per month 2.06  0.03  5.84 (4.07) 12.96 
IMRXImmuneering Corp(0.08)7 per month 5.14  0.13  15.50 (8.68) 60.06 

Oric Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Oric price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oric using various technical indicators. When you analyze Oric charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Oric Pharmaceuticals Predictive Indicators

The successful prediction of Oric Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Oric Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Oric Pharmaceuticals based on analysis of Oric Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Oric Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Oric Pharmaceuticals's related companies.
 2021 2022 2023 2024 (projected)
Current Ratio15.8713.6810.3918.35
Net Debt To EBITDA2.870.70.120.11

Story Coverage note for Oric Pharmaceuticals

The number of cover stories for Oric Pharmaceuticals depends on current market conditions and Oric Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Oric Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Oric Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Oric Pharmaceuticals Short Properties

Oric Pharmaceuticals' future price predictability will typically decrease when Oric Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Oric Pharmaceuticals often depends not only on the future outlook of the potential Oric Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oric Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding51.5 M
Cash And Short Term Investments208.2 M

Complementary Tools for Oric Stock analysis

When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Content Syndication
Quickly integrate customizable finance content to your own investment portal